Global burden of childhood cancer: growing, but controllable
Cette étude présente une estimation, au niveau mondial pour l'année 2017, de l'incidence, de la mortalité par cancer et des années de vies perdues ajustées sur l'incapacité chez les enfants et adolescents atteints d'un cancer (âge inférieur ou égal à 19 ans)
There are many facets to the burden of childhood and adolescent cancer. Unsurprisingly, these are best documented in the predominantly high-income countries that have high-quality population-based cancer registries and death registration systems. In those countries, cancer is largely a disease of older adults, with well under 2% of cases diagnosed in the first 20 years of life (data from the Cancer Today database). More than half a century of progress in therapy and supportive care for children with cancer has resulted in impressive gains in survival and corresponding reductions in population mortality rates in high-income countries. However, this success has come at the price of increased long-term morbidity and mortality among survivors compared with the general population, which must also be counted as part of the cancer burden. In their Article in The Lancet Oncology, Lisa Force and colleagues estimate, for the first time, the global burden of childhood cancer in disability-adjusted life-years (DALYs), taking into account loss of healthy life-years to ill health and disability in addition to death. (...)
The Lancet Oncology , commentaire en libre accès, 2018